The time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.
CEO, D2 Consulting
Advertisement
Articles by CEO, D2 Consulting
The FDA recently launched one of its first programs following the release of the Trump administration’s new drug price plan.
Advertisement
Latest Updated Articles
Federal Drug Price Plan Rollout and Other Trends to WatchPublished: September 11th 2018 | Updated:
Responding Proactively to Antikickback GuidelinesPublished: November 14th 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
Regular Melatonin Supplementation May Hide Hidden Heart Complications
5
